Generex Biotechnology Corporation (GNBT) Touts Pipeline Potential of Antigen Express, Inc. (GNBT) Subsidiary
2/7/2013 10:24:35 AM
More...
|
Generex Biotechnology Corporation (GNBT) Points to Potential of Antigen Express, Inc. (GNBT) Technology Platform Beyond Its AE37 Breast Cancer Vaccine
1/31/2013 9:03:41 AM
More...
|
Antigen Express, Inc. (GNBT) AE37 Breast Cancer Vaccine Featured in "Micro-Cap Review" Interview
1/17/2013 10:15:01 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces Publication of Abstract at American Society of Clinical Oncology 2012 Showing Potential of Antigen Express, Inc. (GNBT) AE37 Immunotherapeutic Cancer Vaccine Technology in Prostate Cancer
6/15/2012 9:37:35 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces OncUView.tv Interviews Featuring the Antigen Express, Inc. (GNBT) AE37 Breast Cancer Vaccine at ASCO 2012
6/14/2012 9:24:29 AM
More...
|
Generex Biotechnology Corporation (GNBT) Augments Antigen Express, Inc. (GNBT) Scientific Advisory Board
5/21/2012 10:20:33 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces New Members of Antigen Express, Inc. (GNBT) Scientific Advisory Board for the AE37 Breast Cancer Vaccine
5/17/2012 8:17:30 AM
More...
|
Generex Biotechnology Corporation (GNBT) Enhances Antigen Express, Inc. (GNBT) Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
5/15/2012 12:42:52 PM
More...
|
Generex Biotechnology Corporation (GNBT) Announces Establishment of a Scientific Advisory Board for Antigen Express, Inc. (GNBT)
5/10/2012 10:01:34 AM
More...
|
Generex Biotechnology Corporation (GNBT) Announces Presentations of Antigen Express, Inc. (GNBT) AE37 Breast Cancer Vaccine Data at American Society of Clinical Oncology 2012
5/9/2012 9:08:09 AM
More...
|
|